EVALUATION OF ALTERED PTEN EXPRESSION BY IHC AS A DIAGNOSTIC MARKER IN HYPERPLASTIC AND NEOPLASTIC ENDOMETRIUM OBSERVATIONAL DESCRIPTIVE STUDY.
Altered PTEN expression by IHC in endometrial disorders
DOI:
https://doi.org/10.51168/sjhrafrica.v4i6.485Keywords:
Endometrial carcinoma, PTEN, IHCAbstract
Introduction:
Endometrial carcinoma is a common cancer affecting women. Different molecular alterations have been described in endometrioid endometrial carcinoma (EC). Among them the most frequently altered is the loss of the PTEN protein, a tumor suppressor gene, leading to microsatellite instability. The purpose of this study was to evaluate the expression pattern of PTEN gene in normal proliferative, hyperplastic, and neoplastic endometrium. Objective: To observe the altered expression of PTEN in proliferative endometrium, endometrial hyperplasia, and endometrial carcinoma.
Methods:
This study was an observational descriptive study conducted in the Department of Pathology, M.K.C.G. Medical College, Brahmpur,Odhisha. over a two-year period in which immuno-histochemical evaluation of PTEN expression was done in 146 patients.
Results:
PTEN immunoreactivity was present in all normal proliferative endometrium, all simple hyperplasia, 50% of atypical hyperplasia, and in none of EC (P < 0.001). The intensity of PTEN reaction was significantly higher in a group with proliferative endometrium than in atypical hyperplastic endometrium and EC (P < 0.001).
Conclusion:
PTEN expression was significantly higher in cyclical endometrium than in atypical hyperplasia and endometrioid carcinoma and PTEN immunostaining may be a new and effective tool for screening malignant and premalignant endometrial lesions
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Dr. Bodhisatwa Behera, Dr. Jayanti Nayak, Dr. Saroj Ranjan Mohanty, Dr. Manoj Kumar Patro, Dr. Sunita Rani Senapati, Dr. Neha Dash
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.